A2 Biotherapeutics Entered Into Collaboration Agreement With Merck to Develop Allogeneic...

A2 Biotherapeutics Entered Into Collaboration Agreement With Merck to Develop Allogeneic Cell Therapy for Solid Tumor Cancers

insitro Announces Five-Year Discovery Collaboration with Bristol Myers Squibb to Discover...

insitro Announces Five-Year Discovery Collaboration with Bristol Myers Squibb to Discover and Develop Novel Treatments for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

AnaptysBio and GlaxoSmithKline Amend Strategic Immuno-Oncology Collaboration

AnaptysBio and GlaxoSmithKline Amend Strategic Immuno-Oncology Collaboration

Iterum Therapeutics Announces Pricing of $17.5 Million Upsized Public Offering –...

Iterum Therapeutics Announces Pricing of $17.5 Million Upsized Public Offering - Oct 23, 2020

Zydus receives approval from COFEPRIS to conduct clinical trials in Mexico...

Zydus receives approval from COFEPRIS to conduct clinical trials in Mexico with Pegylated Interferon alpha-2b to treat novel Coronavirus - FirstWord Pharma
- Advertisement -

LATEST NEWS

MUST READ